AI MARKET SCANNING

Ascendis Pharma A/S

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -1.05%
MAX GAP RECORD -13.11%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ASND
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN)
-1.99%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
-5.29%
Feb 11, 2026 Earnings Release 2026-02-11 (AFTER CLOSE)
-4.74%
Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE)
-3.48%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
+3.80%
Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE)
+0.33%
Feb 12, 2025 Earnings Release 2025-02-12 (AFTER CLOSE)
+10.00%
Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE)
-4.26%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.7%
Bullish Gaps (4)
Bearish Gaps (7)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ASND

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗